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Background: Congenital myopathies (CMs) are a genetically and 
clinically heterogeneous group of neuromuscular disorders. Historically, the 
congenital myopathies are classified according to muscle biopsy findings – Rods 
(Nemaline myopathy) (NM), cores (central core disease and multiminicore
disease) (Core and MMC), central nuclei (centronuclear/ myotubular
myopathy)(CNM) , and selective hypotrophy of type 1 fibres ( congenital fibre 
type disproportion CFD). Over twenty genes have been implicated in CMs. The 
overlapping clinical presentations among different histopathological findings 
and different mutations poses major diagnostic challenge.
Objective: We investigated the characteristics of children with congenital 
myopathies in Hong Kong. 
Patients and methods:  We identified all patients with a confirmed 
diagnosis of CM between 2012-March 2015. Their clinical presentation , muscle 
biopsy, muscle MRI and genetic analysis results were evaluated. 
Results:  
Patients: 
Total 15 patients have been diagnosed to have CM. Nine were males (60%), 6 were 
female (40%). 
Genetic findings: 
(1) A genetic diagnosis could be established in 11 (73%) out of 15 patients.  
Among those 11 patients, 4 (36%) were mutated in RYR1, 3 (27%) in ACTA1, 
2 (18%) in KLHL40 , 1 (9%) in  MTM1 and 1 (9%) in DNM2. A total of 13  
mutation were identified.
(2) The missense RYR1 mutation (c.3523G>A) was found in 2 patients, and the 
missense KLHL40 mutation (c.1516A>C) was found in another 2 patients, 
suggesting that these variants could probably be the hot spots mutation 
among Chinese patients. 
(3) Pathological heterogeneity caused by RYR1 mutation is shown in our 4 
patients showing different findings including nemaline rods, central cores, 
multiminicores, or type 1 fibre predominance. 
Histopathological features: 
(1) Muscle biopsy evaluation were available in all 15 patients. Nemaline
myopathy were the most frequent histopathological diagnosis, in 5 
patients (33%), followed by core myopathy, in 4 patients (26%), 
centronuclear myopathy in 2 patients (13%), congenital fibre type 
disproportion in 2 patients (13%), zebra bodies in 1 (6.7%) patient and type 
1 predominance in 1 (6.7 %) patient. 
(2) Genetic heterogeneity is illustrated in our patients with nemaline
myopathy. Amongst the 5 patients, 1 had RYR1, 2 had ACTA1 and 2 had  
KLHL40 mutation. 
Clinical features: 
(1) Of the 15 patients, 9 (60%) had age of onset at birth or before one month, 
3 (20%) between 1 and 12 months, and 3 (20%) between 1 and 5 years. Out 
of the 9 patients with early neonatal presentation,  3/9 (33%) patients died 
before 13 months. 
(2) The functional abilities varied from very severe weakness required tube 
feeding and ventilation support , to intermediate functional abilities with 
possible independent sitting , to mild limb girdle weakness only. 
(3) ACTA1, KLHL40, DNM2 and MTM1 mutations are associated with severe 
presentation with early neonatal onset . 
(4) RYR1 mutations are associated with a milder phenotype with all the 
affected patients maintain independent walking 
Muscle imaging: 
Selective muscle involvement with Rectus Femoris sparing provides helpful clues 
to a possible underlying RYR1 mutation.  
Gene M.  
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1 ACTA1 ZB M < 1wk Died 13 m Lyer Weakness+++ - + NIV PEG
2 ACTA1 NM M 1m 7 y Sitter (S) Floppy baby - + NIV PEG
3 ACTA1 NM F <1m 11 m Lyer Weakness +++ - + NIV PEG
4 KLHL40 NM F Birth Died 7 m Lyer Weakness +++ + + IV TF
5 KLHL40 NM M Birth 9.5 m Lyer Weakness + + NIV PEG
6 RYR1 NM F <1 11.8 y Walker Unsteady gait + - - +  oral
7 RYR1 Core M <5 20 y Walker
Tip toe 
walking
- - - -
8 RYR1 MMC M <1 4.7 y Walker Floppy baby - - - -
9 RYR1 TIP F <1 22.7 y Walker Floppy baby - - - -
10 MTM1 CNM M Birth 17 y Sitter (S) Weakness+++ + - + +  oral
11 DNM2 CNM M <1m Died 10 m Lyer Floppy baby + - +  oral 
12 * C & R M Birth 22 y Sitter Weakness+++ - + NIV PEG
13 Pending MMC M <5 14.1 y Walker Clumsiness - - - -
14 ** CFD F <3 m 4 y Walker (S) Floppy baby + - - -
15 Pending CFD F 1.5y 24 y Sitter Delay walking - - + -
* No mutation found in RYR1, ACTA1, SEPN1, KBTBD13; ** No mutation found in RYR1, ACTA1, SEPN1, TPM2, TPM3; (S) – supported; ZB: zebra 
bodies; NM: Nemaline myopathy; Core and MMC: core and multiminicore myopathy; CNM: centronuclear myopathy; CFD: congenital fibre type 
disproportion; TIP: type 1 disproportion; C&R; cores and rods; Motor Fn: Motor function; EOM: extraocular muscles involvement; IV/ NIV: 
invasive ventilation/ non-invasive ventilation; PEG: Gastrostomy 
Gene Muscle 
biopsy
Mutation Inheritance 
Pattern
Parents’
carrier status
1 ACTA1 ZB c.529A>G (p.Ile177Val) AD No
2 ACTA1 NM c.802T>C (p.Phe268Leu) AD No
3 ACTA1 NM c.547G>A (p.Ala183Thr)  AD No
4 KLHL40 NM c.1516A>C(p.Thr506Pro) AR Yes
5 KLHL40 NM c.1327G>A(p.Gly443Ser) + c.1516A>C(p.Thr506Pro) AR Yes
6 RYR1 NM c.3800C>G (p.Pro1267Arg) + c.1675dup (p.11e559Asnfs*11) AD Yes
7 RYR1 Core c.7523G>A (p.Arg2508His) AR No
8 RYR1 MMC
c.3523G>A (p.Glu1175Lys) + c.11956dupG 
(p.Asp3986Glyfs*89)
AR Yes
9 RYR1 TIP
c.3523G>A (p.Glu1175Lys) + c.10615delC 
(p.Arg3539Valfs*4)
AR Yes
10 MTM1 CNM c.1644+2T>C (p?) a splicing mutation X-linked No
11 DNM2 CNM c.1124T>A (p. Val375Glu) AD No
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(a &b). Electron microscopy (EM) of muscle biopsies of patients 4 & 5 with nemaline myopathy 
due to  KLHL40 mutation with roundish rods; (c&d). Electron microscopy of muscle biopsies of 
patient 2 & 3 with nemaline myopathy due to ACTA1 mutation;  (e) Muscle biopsy of patient 12 
with central core disease having rods shown on EM; (f) A zebra body is noted on the EM of 
patient 1 with ACTA1-related congenital myopathy when the muscle biopsy was performed at 1.5 
month old;  (g & h) Muscle biopsy of patient 13 with multi-minicores on the EM; (i & j) Muscle 
biopsy of patient 8 with multi-minicore disease due to RYR1 mutation showing uneven staining 
with SDH in some fibres and EM shows a large minicore with excess Z-line material and 
myofilament disruption; (k & l) Muscle biopsy of patient 7 with central core myopathy due to 
RYR1 mutation with NADH shows numerous cores and EM shows a central core in the centre with 
disrupted Z-line. (m & n) Muscle biopsy of patient 11 with centronuclear myopathy due to DNM2
mutation. Central nuclei are seen in some fibres (H&E) and no radiating strands are noted from 
the central nuclei (NADH). 
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